http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014275035-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2808f5779912ea7fdb826981e34ce015 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14 |
| filingDate | 2014-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20d2d4aa77ea8a4f5f98e9c4436f4b88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2edd064620f3fcb56312aa177701aca2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf128d7fad8e49a8c684b5f5d99f20e7 |
| publicationDate | 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2014275035-A1 |
| titleOfInvention | Thienylindole azepines as serotonin 5-ht2c receptor ligands and uses thereof |
| abstract | The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are thienylindole azepines. These compounds are serotonin receptor (5-HT 2c ) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT 2c ) is desired (e.g. addiction, anxiety, depression, obesity, and others). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018166855-A1 |
| priorityDate | 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 779.